Linagliptin and Temozolomide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Linagliptin (linagliptin) and Temozolomide (temozolomide). Common drug interactions include nausea among males.
The phase IV clinical study analyzes what interactions people have when they take Linagliptin and Temozolomide. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Linagliptin?
Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.
What is Temozolomide?
Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 16,644 Temozolomide users. Check the latest studies of Temozolomide.
15 people who take Linagliptin and Temozolomide together, and have interactions are studied.
What are the common drug interactions of Linagliptin and Temozolomide, by gender? *:
female:
n/a
male:
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Ageusia (loss of taste functions of the tongue)
- Decreased appetite
- Asthenia (weakness)
- Bradycardia (abnormally slow heart action)
- Dehydration (dryness resulting from the removal of water)
- Death
- Hospitalisation
- Loss of consciousness
What are the common drug interactions of Linagliptin and Temozolomide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Ageusia (loss of taste functions of the tongue)
- Decreased appetite
- Asthenia (weakness)
- Bradycardia (abnormally slow heart action)
- Dehydration (dryness resulting from the removal of water)
- Death
- Hospitalisation
- Loss of consciousness
What are the existing conditions these people have? *
- Nasopharyngeal Cancer (cancer of nasopharynx): 4 people, 26.67%
- Brain Neoplasm Malignant (brain cancer tumour): 3 people, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Linagliptin and Temozolomide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Linagliptin (8,112 reports)
- Temozolomide (16,644 reports)
Browse all drug interactions of Linagliptin and Temozolomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Linagliptin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Temozolomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Linagliptin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Temozolomide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on linagliptin and temozolomide (the active ingredients of Linagliptin and Temozolomide, respectively), and Linagliptin and Temozolomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Multiple Myeloma and Asthma - 3 seconds ago
- Drug interactions of Lyrica and Methadone Hydrochloride - 4 seconds ago
- Sinemet vs. Clonazepam, side effect and effectiveness comparison - 5 seconds ago
- Toradol vs. Oxycodone And Aspirin, side effect and effectiveness comparison - 9 seconds ago
- Drug interactions of Exforge and Amlodipine Besylate - 10 seconds ago
- Drug interactions of Carvedilol and Protamine Sulfate - 10 seconds ago
- Could Rifampin cause Constipation? - 12 seconds ago
- Fenofibrate vs. Omega-3 Oil, side effect and effectiveness comparison - 13 seconds ago
- Could Perindopril Erbumine cause Pruritus Aggravated? - 15 seconds ago
- Drug interactions of Felodipine and Gatifloxacin - 19 seconds ago